131 related articles for article (PubMed ID: 33340712)
61. Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort.
Lonergan PE; Cowan JE; Washington SL; Greenberg SA; Nguyen HG; Carroll PR
Prostate; 2021 Sep; 81(13):1009-1017. PubMed ID: 34288004
[TBL] [Abstract][Full Text] [Related]
62. Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
Thomas J; Gupta M; Grasso Y; Reddy CA; Heston WD; Zippe C; Dreicer R; Kupelian PA; Brainard J; Levin HS; Klein EA
J Clin Oncol; 2002 Aug; 20(15):3213-8. PubMed ID: 12149293
[TBL] [Abstract][Full Text] [Related]
63. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
Hsu CC; Paciorek AT; Cooperberg MR; Roach M; Hsu IC; Carroll PR
BJU Int; 2015 Nov; 116(5):713-20. PubMed ID: 25600860
[TBL] [Abstract][Full Text] [Related]
64. Persistently elevated prostate-specific antigen at six weeks after radical prostatectomy helps in early identification of patients who are likely to recur.
Audenet F; Seringe E; Drouin SJ; Comperat E; Cussenot O; Bitker MO; Rouprêt M
World J Urol; 2012 Apr; 30(2):239-44. PubMed ID: 21638225
[TBL] [Abstract][Full Text] [Related]
65. Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy.
Coetzee LJ; Hars V; Paulson DF
Urology; 1996 Feb; 47(2):232-5. PubMed ID: 8607240
[TBL] [Abstract][Full Text] [Related]
66. Treatment Outcomes from
Emmett L; van Leeuwen PJ; Nandurkar R; Scheltema MJ; Cusick T; Hruby G; Kneebone A; Eade T; Fogarty G; Jagavkar R; Nguyen Q; Ho B; Joshua AM; Stricker P
J Nucl Med; 2017 Dec; 58(12):1972-1976. PubMed ID: 28747524
[No Abstract] [Full Text] [Related]
67. Declining Use of Radiotherapy for Adverse Features After Radical Prostatectomy: Results From the National Cancer Data Base.
Sineshaw HM; Gray PJ; Efstathiou JA; Jemal A
Eur Urol; 2015 Nov; 68(5):768-74. PubMed ID: 25896124
[TBL] [Abstract][Full Text] [Related]
68. Role of radical prostatectomy in patients with prostate cancer of high Gleason score.
Tefilli MV; Gheiler EL; Tiguert R; Banerjee M; Sakr W; Grignon D; Wood DP; Pontes JE
Prostate; 1999 Apr; 39(1):60-6. PubMed ID: 10221268
[TBL] [Abstract][Full Text] [Related]
69. Recurrence after radical prostatectomy for organ-confined prostate cancer.
Scheepe JR; Vis AN; Mickisch GH
Onkologie; 2003 Aug; 26(4):330-3. PubMed ID: 12972697
[TBL] [Abstract][Full Text] [Related]
70. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database.
Grossfeld GD; Chang JJ; Broering JM; Miller DP; Yu J; Flanders SC; Henning JM; Stier DM; Carroll PR
J Urol; 2000 Apr; 163(4):1171-7; quiz 1295. PubMed ID: 10737489
[TBL] [Abstract][Full Text] [Related]
71. Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era.
Lin DD; Schultz D; Renshaw AA; Rubin MA; Richie JP; D'Amico AV
Urology; 2005 Mar; 65(3):528-32. PubMed ID: 15780370
[TBL] [Abstract][Full Text] [Related]
72. Robot-assisted laparoscopic radical prostatectomy in patients with prostate cancer with high-risk features: predictors of favorable pathologic outcome.
Uberoi J; Brison D; Patel N; Sawczuk IS; Munver R
J Endourol; 2010 Mar; 24(3):403-7. PubMed ID: 20078237
[TBL] [Abstract][Full Text] [Related]
73. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.
Kneebone A; Fraser-Browne C; Duchesne GM; Fisher R; Frydenberg M; Herschtal A; Williams SG; Brown C; Delprado W; Haworth A; Joseph DJ; Martin JM; Matthews JHL; Millar JL; Sidhom M; Spry N; Tang CI; Turner S; Wiltshire KL; Woo HH; Davis ID; Lim TS; Pearse M
Lancet Oncol; 2020 Oct; 21(10):1331-1340. PubMed ID: 33002437
[TBL] [Abstract][Full Text] [Related]
74. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
75. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
J Clin Oncol; 1996 Jun; 14(6):1770-7. PubMed ID: 8656245
[TBL] [Abstract][Full Text] [Related]
76. Understanding the Tradeoffs Between Travel Burden and Quality of Care for In-center Hemodialysis Patients.
Salerno S; Gremel G; Dahlerus C; Han P; Affholter J; Tong L; Wisniewski K; Roach J; Li Y; Hirth RA
Med Care; 2022 Mar; 60(3):240-247. PubMed ID: 34974490
[TBL] [Abstract][Full Text] [Related]
77. Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml.
Shao YH; Albertsen PC; Roberts CB; Lin Y; Mehta AR; Stein MN; DiPaola RS; Lu-Yao GL
Arch Intern Med; 2010 Jul; 170(14):1256-61. PubMed ID: 20660846
[TBL] [Abstract][Full Text] [Related]
78. Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era.
Fairey AS; Daneshmand S; Skinner EC; Schuckman A; Cai J; Lieskovsky G
Urol Oncol; 2014 Feb; 32(2):85-91. PubMed ID: 24183191
[TBL] [Abstract][Full Text] [Related]
79. A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution.
Martinez AA; Gonzalez JA; Chung AK; Kestin LL; Balasubramaniam M; Diokno AC; Ziaja EL; Brabbins DS; Vicini FA
Cancer; 2000 Jan; 88(2):425-32. PubMed ID: 10640977
[TBL] [Abstract][Full Text] [Related]
80. Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels.
Humphrey PA; Frazier HA; Vollmer RT; Paulson DF
Cancer; 1993 Mar; 71(5):1821-7. PubMed ID: 7680602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
